Nine of these patients developed mild-to-moderate rash while receiving therapy with efavirenz, and two discontinued because of rash.
Nende seast üheksal tekkis kerge kuni mõõdukas nahalööve ja 2 patsienti katkestas lööbe tõttu ravi.